(Q33745113)

English

Multiplexed assessment of the Southwest Oncology Group-directed Intergroup Breast Cancer Trial S9313 by AQUA shows that both high and low levels of HER2 are associated with poor outcome

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Multiplexed assessment of the Southwest Oncology Group-directed Intergroup Breast Cancer Trial S9313 by AQUA shows that both high and low levels of HER2 are associated with poor outcome (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Peggy L. Porter

4

object named as

Peggy L Porter

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

9

object named as

George Sledge

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

11

object named as

James N Ingle

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

author name string

Malini Harigopal

1

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

William E Barlow

2

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Greg Tedeschi

3

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

I-Tien Yeh

5

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Charles Haskell

6

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Robert Livingston

7

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Gabriel N Hortobagyi

8

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Charles Shapiro

10

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

David L Rimm

12

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Daniel F Hayes

13

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

language of work or name

0 references

publication date

11 February 2010

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

The American Journal of Pathology

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

176

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

1639-1647

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A status

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843456

21 June 2018

A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843456

21 June 2018

Chemosensitivity and stratification by a five monoclonal antibody immunohistochemistry test in the NSABP B14 and B20 trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843456

21 June 2018

Comparison of quantitative immunofluorescence with conventional methods for HER2/neu testing with respect to response to trastuzumab therapy in metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843456

21 June 2018

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843456

21 June 2018

Layered peptide array for multiplex immunohistochemistry

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843456

21 June 2018

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843456

21 June 2018

Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843456

21 June 2018

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843456

21 June 2018

p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843456

21 June 2018

Autoantibody detection using multiplex technologies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843456

21 June 2018

Multispectral imaging of clinically relevant cellular targets in tonsil and lymphoid tissue using semiconductor quantum dots

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843456

21 June 2018

Quantitative in situ analysis of beta-catenin expression in breast cancer shows decreased expression is associated with poor outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843456

21 June 2018

Automated quantitative analysis (AQUA) of in situ protein expression, antibody concentration, and prognosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843456

21 June 2018

Quantifying estrogen and progesterone receptor expression in breast cancer by digital imaging

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843456

21 June 2018

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843456

21 June 2018

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843456

21 June 2018

Rolling circle amplification: a new approach to increase sensitivity for immunohistochemistry and flow cytometry.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843456

21 June 2018

Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843456

21 June 2018

Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843456

21 June 2018

p53 gene mutations inside and outside of exons 5-8: the patterns differ in breast and other cancers.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843456

21 June 2018

Progesterone receptors as a prognostic factor in Stage II breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843456

21 June 2018

The cytochemical detection of oestrogen receptors in fine needle aspirates of breast cancer; correlation with biochemical assay and prediction of response to endocrine therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843456

21 June 2018

Correlation between ERICA and DCC assay in hormone receptor assessment of human breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843456

21 June 2018

Immunocytochemical analysis of estrogen receptors in human breast carcinomas. Evaluation of 130 cases and review of the literature regarding concordance with biochemical assay and clinical relevance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843456

21 June 2018

21 Quantitation of estrogen receptor in mammary carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843456

21 June 2018

Breast cancer testing scandal shines spotlight on black box of clinical laboratory testing.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843456

30 October 2018

Sequenced compared with simultaneous anthracycline and cyclophosphamide in high-risk stage I and II breast cancer: final analysis from INT-0137 (S9313).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843456

30 October 2018

Reporting recommendations for tumor marker prognostic studies (REMARK).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843456

30 October 2018

Immunohistochemistry of estrogen and progesterone receptors reconsidered: experience with 5,993 breast cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843456

30 October 2018

Automated subcellular localization and quantification of protein expression in tissue microarrays.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843456

30 October 2018

HER2 and Response to Paclitaxel in Node-Positive Breast Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2843456

30 October 2018

Estrogen receptor (ER) and progesterone receptor (PgR), by ligand-binding assay compared with ER, PgR and pS2, by immuno-histochemistry in predicting response to tamoxifen in metastatic breast cancer: a Southwest Oncology Group Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20150438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative analysis of breast cancer tissue microarrays shows that both high and normal levels of HER2 expression are associated with poor outcome

1 reference

https://pubmed.ncbi.nlm.nih.gov/20150438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The value of estrogen and progesterone receptors in the treatment of breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20150438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/20150438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunohistochemical measurement of estrogen receptors in breast cancer tissue samples

1 reference

https://pubmed.ncbi.nlm.nih.gov/20150438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic significance of progesterone receptor levels in estrogen receptor-positive patients with metastatic breast cancer treated with tamoxifen: results of a prospective Southwest Oncology Group study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20150438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new immunohistochemical antibody for the assessment of estrogen receptor status on routine formalin-fixed tissue samples

1 reference

https://pubmed.ncbi.nlm.nih.gov/20150438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estrogen receptor immunocytochemistry in paraffin embedded tissues with ER1D5 predicts breast cancer endocrine response more accurately than H222Sp gamma in frozen sections or cytosol-based ligand-binding assays

1 reference

https://pubmed.ncbi.nlm.nih.gov/20150438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prognostic importance of low c-erbB2 expression in breast tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/20150438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative determination of c-erbB-2 in human breast tumours: potential prognostic significance of low values

1 reference

https://pubmed.ncbi.nlm.nih.gov/20150438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antibody dependent cellular phagocytosis (ADCP) and antibody dependent cellular cytotoxicity (ADCC) of breast cancer cells mediated by bispecific antibody, MDX-210

1 reference

https://pubmed.ncbi.nlm.nih.gov/20150438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization

1 reference

https://pubmed.ncbi.nlm.nih.gov/20150438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bimodal frequency distribution of estrogen receptor immunohistochemical staining results in breast cancer: an analysis of 825 cases

1 reference

https://pubmed.ncbi.nlm.nih.gov/20150438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Estrogen receptor testing of breast cancer in current clinical practice: what's the question?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20150438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative measures of oestrogen receptor and ERBB2 expression

1 reference

https://pubmed.ncbi.nlm.nih.gov/20150438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bimodal population or pathologist artifact?

1 reference

https://pubmed.ncbi.nlm.nih.gov/20150438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Human Epidermal Growth Factor Receptor 2 Overexpression As a Prognostic Factor in a Large Tissue Microarray Series of Node-Negative Breast Cancers

1 reference

https://pubmed.ncbi.nlm.nih.gov/20150438

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.2353/AJPATH.2010.090711

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33745113&oldid=1669666767"